$2.20
At close: Mar 24, 11:40 AM EDT
Comments
Loading...
Selectis Health Analyst Ratings and Price Targets | OTC:GBCS | Benzinga
Selectis Health Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Selectis Health Corp from these most-recent analyst ratings.
Analyst Ratings for Selectis Health
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Selectis Health (GBCS) stock?
There is no price target for Selectis Health
What is the most recent analyst rating for Selectis Health (GBCS)?
There is no analyst for Selectis Health
When was the last upgrade for Selectis Health (GBCS)?
There is no last upgrade for Selectis Health
When was the last downgrade for Selectis Health (GBCS)?
There is no last downgrade for Selectis Health.
When is the next analyst rating going to be posted or updated for Selectis Health (GBCS)?
There is no next analyst rating for Selectis Health.
Is the Analyst Rating Selectis Health (GBCS) correct?
There is no next analyst rating for Selectis Health.
Browse analyst ratings and price targets on all stocks.
